Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LipiVage

K-Number: K172714 · 2017-12-08

Decision Date2017-12-08
Product CodeMUU
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

LipiVage is a medical device manufactured by Genesis Biosystems, Inc.. It received FDA 510(k) clearance on 2017-12-08 under approval number K172714. The device is classified under product code MUU. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LipiVage?

LipiVage is a medical device that received FDA 510(k) clearance on 2017-12-08. It is manufactured by Genesis Biosystems, Inc.. The 510(k) number is K172714.

When was LipiVage approved by the FDA?

LipiVage received FDA 510(k) clearance on 2017-12-08, under approval number K172714.

What company makes LipiVage?

LipiVage is manufactured by Genesis Biosystems, Inc..

What is the FDA product code for LipiVage?

The FDA product code for LipiVage is MUU.

Related Devices (Code: MUU)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.